Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients
Titel:
Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients
Auteur:
Borthakur, Gautam Tallman, Martin Ofran, Yishai Foran, James Uy, Geoffrey DiPersio, John Nagler, Arnon Rowe, Jacob Showel, Margaret Altman, Jessica Peled, Amnon Abraham, Michal Pereg, Yaron Vainstein, Abi Oberkovitz, Galia Lustig, Tzipi Aharon, Arnon Bueso-Ramos, Carlos Cortes, Jorge Andreeff, Michael